In addition, we have found that treating HCC rats with CAY10500 significantly increased rats’ survival, reduced the number of nodules per nodule-bearing liver, reduced serum AFP levels, and was associated with improvement in the structure of hepatocytes and reduction of the mitotic score. Here, AFP is linked to hepatocellular carcinoma.